8-K: Retractable Technologies Declares Preferred Dividends

Retractable Technologies, Inc. announced dividends for its Series II and Series III Class B Convertible Preferred Stock shareholders.

Summary

• Retractable Technologies, Inc. (NYSE American: RVP) declared dividends for its Series II Class B and Series III Class B Convertible Preferred Stock shareholders.
• Dividends for Series II Class B Preferred Stock amount to $39,050.00.
• Dividends for Series III Class B Preferred Stock amount to $18,561.25.
• Dividends accrued at a rate of $1.00 per share per annum.
• The declared dividends cover the period from October 1, 2025, through December 31, 2025.
• Dividends will be paid on January 20, 2026, to shareholders of record as of the close of business on January 10, 2026.
• The company manufactures and markets VanishPoint and Patient Safe safety medical products, as well as the EasyPoint needle, designed to prevent needlestick injuries and reduce infection risks.

Sentiment

Score: 7

Explanation: The declaration of preferred stock dividends is a positive signal for preferred shareholders, indicating the company's ability to meet its obligations. For common shareholders, it's a neutral event, confirming ongoing financial operations without direct impact on common stock value from this specific announcement.

Positives

• Declaration of dividends for Series II Class B and Series III Class B Convertible Preferred Stock shareholders, indicating the company's ability to meet its preferred obligations.
• Consistent dividend accrual at $1.00 per share per annum for the preferred stock.

Risks

• Potential impact of tariffs on operations and costs.
• Material changes in demand for the company's products.
• Ability to maintain sufficient liquidity to support operations.
• Maintenance of patent protection for proprietary products.
• Ability to maintain favorable third-party manufacturing and supplier arrangements and relationships.
• Exposure to foreign trade risks.
• Challenges in accessing the market for its medical devices.
• Fluctuations in production costs.
• Competition and impact from larger market players in the safety medical device market.
• Other risks and uncertainties detailed from time to time in periodic reports filed with the U.S. Securities and Exchange Commission.

Future Outlook

Forward-looking statements reflect current views with respect to future events, but actual future performance could differ materially from such statements. Factors that could cause differences include tariffs, material changes in demand, the company's ability to maintain liquidity, patent protection, favorable third-party manufacturing and supplier arrangements, foreign trade risk, market access, production costs, and the impact of larger market players.

Management Comments

• The Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively.

Industry Context

Retractable Technologies operates within the medical device sector, specializing in safety-engineered products like syringes and needles designed to mitigate risks such as needlestick injuries and bloodstream infections. The declaration of preferred stock dividends is a standard financial activity for companies in this industry, reflecting ongoing operational stability rather than a specific industry trend or innovation.

Stakeholder Impact

• **Preferred Shareholders:** Will receive the declared dividends, positively impacting their investment returns and confirming the company's commitment to its preferred stock obligations.
• **Common Shareholders:** No direct impact on common stock value from this specific preferred dividend declaration, but it confirms the company's ongoing financial operations.
• **Customers/Suppliers:** No direct impact from this announcement.
• **Employees:** No direct impact from this announcement.

Next Steps

• Payment of declared dividends to preferred shareholders on January 20, 2026.
• Continued manufacturing and marketing of VanishPoint, Patient Safe, and EasyPoint medical products.
• Ongoing compliance with SEC reporting requirements through periodic filings.

Key Dates

Keywords

Retractable Technologies, RVP, Dividends, Preferred Stock, Medical Devices, Safety Syringes, VanishPoint, Patient Safe, EasyPoint, SEC Filing